Lexaria is poised to revolutionize the age-old ritual of afternoon tea.
Marijuana Industry
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
Rising Demand for Cannabis Oils Pushes Canada’s Producers into Overdrive
As one of Canada’s first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities.
CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 42% Month-Over-Month Revenue Growth in October
PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Wins in Vegas!
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) had a full team at its exhibit, which attracted a lot of attention.
Outsized Demand in Canada’s Cannabis Market Triggers Upswing in Smart Money Flowing North
For 17 years Canada has provided legal access to medical cannabis to its citizens, and now the country is expected to legalize recreational marijuana by July 2018.
Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Merger and Acquisition Activity is Heating Up in the Cannabis Industry
Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity.
AV1 Group, Inc. (AVOP) Noteworthy Amid Growing Cannabis Industry
AV1 Group (OTC: AVOP) is building its focus of identifying, securing and monetizing companies with emerging growth potential.
Innovation Drives Value for Leading Cannabis Biotechs
As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.
Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis
InMed Pharmaceuticals, Inc. has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids.